(Q53487037)
Statements
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. (English)
T K Kvien
1 reference
G R Burmester
1 reference
E Keystone
C G Peterfy
P P Tak
S Cohen
M C Genovese
M Dougados
M Greenwald
S Williams
D Hagerty
M W Cravets
T Shaw
3 April 2008
216-221